Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.835
+0.125 (2.65%)
Aug 13, 2025, 9:41 AM - Market open
Cryo-Cell International Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cryo-Cell International stock has a target of 8.50, which predicts a 75.80% increase from the current stock price of 4.84.
Price Target: $8.50 (+75.80%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Cryo-Cell International is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $8.5 | Strong Buy | Maintains | $9 → $8.5 | +75.80% | Mar 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +148.19% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
32.55M
from 31.99M
Increased by 1.75%
Revenue Next Year
32.53M
from 32.55M
Decreased by -0.05%
EPS This Year
-0.12
from 0.05
EPS Next Year
-0.05
from -0.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 33.5M | 33.5M |
| Avg | 32.5M | 32.5M |
| Low | 31.3M | 31.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 4.7% | 2.9% |
| Avg | 1.8% | -0.0% |
| Low | -2.2% | -4.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.13 | -0.05 |
| Avg | -0.12 | -0.05 |
| Low | -0.12 | -0.05 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.